Edit PR Newswire
04 Sep 2012
 . , Sept. 4, 2012 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue.. Global Pulmonary Arterial Hypertension (PAH) Therapeutics Industry ... This report analyzes the worldwide markets for Pulmonary Arterial Hypertension (PAH) Therapeutics in US$ Million ... I ... Disclaimers I-2 ... 1 ... Ergonex Pharma and Pfizer Sign Agreement for Terguride II-26 ... Terguride Investigational PAH Treatment II-27....(size: 53.0Kb)
Edit PR Newswire
23 Apr 2012
 . , April 23, 2012 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue.. Pulmonary Arterial Hypertension (PAH) Therapeutics - Global Drug Forecasts and Treatment Analysis to 2020 ... Pulmonary Arterial Hypertension (PAH) Therapeutics - Global Drug Forecasts and Treatment Analysis to 2020. Summary ... Scope ... Reasons to buy ... 3.4 82 ... 10.1.4 Pfizer Acquires Terguride from ErgoNex Pharma 268....(size: 81.8Kb)